AI Skin Feature Deviation Analysis for Clinical Risk Triage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing automated skin inspection systems struggle with managing stable chronic features and non-clinical variations in image capture, leading to false positive alerts and inadequate assessment of clinical risk due to factors like user positioning and ambient lighting changes.

Innovation Solution

A method using two machine learning models to analyze a feature's detected and predicted states, considering historical data and contextual information, to classify deviations into clinical risk categories, thereby reducing false positives and improving accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a machine learning model focuses solely on feature detection to monitor skin changes, then the system can identify abnormalities, but it generates false positive alerts for stable chronic features like scar tissue and calluses

Engineering Contradiction:
Improveaccuracy of abnormality detectionVSAvoidfalse positive alerts
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The system performs preliminary classification of skin features into acute and chronic categories using historical data analysis. By pre-identifying stable chronic features before they trigger alerts, the system can exclude them from abnormality detection, thereby reducing false positives while maintaining detection accuracy for actual abnormalities.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements feedback loops that continuously monitor detected features over time and adjust detection sensitivity based on observed stability patterns. Features that consistently show no change over multiple monitoring periods are automatically flagged as stable chronic features, creating a self-learning mechanism that reduces false alerts while preserving detection reliability.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If the system performs detailed analysis of all detected features to improve diagnostic accuracy, then clinical risk assessment improves, but the computational complexity and processing time increase

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidcomputational complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The analysis system is segmented into two distinct processing pathways: one for acute features requiring detailed diagnostic analysis and another for chronic features using simplified stability monitoring. This segmentation allows the system to apply computationally intensive analysis only where necessary, maintaining diagnostic accuracy for critical cases while reducing overall computational complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different levels of analysis quality are applied to different feature types based on their clinical significance. Acute features receive comprehensive detailed analysis with high measurement precision, while stable chronic features undergo simplified monitoring. This local differentiation of analysis quality maintains diagnostic accuracy for critical abnormalities while reducing unnecessary computational complexity.

Inventive Principle:
Principle #3Local quality

3Reliability

If the system compares current skin state with historical data to track changes over time, then longitudinal analysis improves, but the system cannot distinguish between expected healing changes and unexpected abnormalities

Engineering Contradiction:
Improvelongitudinal tracking accuracyVSAvoidcontextual information about expected changes
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The system introduces an intermediary classification layer that categorizes features as acute or chronic based on their temporal patterns and clinical characteristics. This intermediary classification provides contextual information that mediates between raw historical data comparison and final interpretation, enabling the system to distinguish expected healing changes in chronic features from unexpected abnormalities in acute features.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system dynamically changes analysis parameters based on feature classification. For chronic features showing expected healing trajectories, the system adjusts sensitivity thresholds and accepts greater variability. For acute features or deviations from expected patterns, the system increases sensitivity and triggers detailed analysis. This parameter adaptation preserves longitudinal tracking accuracy while incorporating contextual understanding of expected changes.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20260066133A1Ai-based method for analyzing deviations between observed and predicted skin feature characteristics
Publication Date: 2026.03.05 BLUEDROP MEDICAL LTD
  • US20260066133A1 patent drawing
  • US20260066133A1 patent drawing
  • US20260066133A1 patent drawing

AI summary

A method for analyzing a feature of interest using a skin inspection system is disclosed. The method comprises generating a first output from a first machine learning model, which analyzes a current image dataset from a skin inspection device to determine a detected state of the feature on a user's skin. A second machine learning model generates a second output comprising a predicted state of the feature, based on historical data for that feature. A processor compares the first output (the detected state) with the second output (the predicted state) to determine a deviation. Finally, the determined deviation is classified into one of a plurality of predefined clinical risk categories.